(Q34181966)

English

Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

based on heuristic

inferred from title

Edward A. Stadtmauer

2

object named as

Stadtmauer EA

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Schulman KA

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Reed SD

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Glick HA

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Goldstein LJ

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Pines JM

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jackman JA

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Suzuki S

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Styler MJ

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Crilley PA

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Klumpp TR

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Mangan KF

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Glick JH

13

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

205-210

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703795

0 references

High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703795

21 January 2018

High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703795

21 January 2018

High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703795

21 January 2018

Much ado about not...enough data: high-dose chemotherapy with autologous stem cell rescue for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703795

21 January 2018

Use of alternative medicine by women with early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703795

21 January 2018

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703795

21 January 2018

Researchers struggle with trials of stem-cell transplants for breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703795

21 January 2018

High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703795

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703795

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment choices by seriously ill patients: the Health Stock Risk Adjustment model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703795

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703795

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34181966&oldid=1947268782"